#Global Trends – Page 13 – HEALTHCARE INSIGHTS

Key Development On September 8, 2026, Swiss generic and biosimilar manufacturer Sandoz Group AG officially presented its long-term commercial transformation... Read more

Tag: #Global Trends

Targeted Thoracic Immuno-Oncology: Amgen’s DLL3-Directed T-Cell Engager Imdelltra® (Tarlatamab) Demonstrates Landmark Overall Survival Improvement in Phase 3 DeLLphi-305 Trial – Establishing New First-Line Maintenance Paradigm in Extensive-Stage SCLC

Biopharmaceutical Manufacturing & Biosimilar Expansion: Sandoz Unveils “Bio100” Long-Term Roadmap Targeting 100+ Biosimilars by 2040 – Commits $300M to New Biomanufacturing Facility in Slovenia to Capture $300B Patent Expiration Wave

NOVARTIS’ PELACARSEN FAILURE RAISES THE BAR FOR Lp(a) THERAPIES AND INTENSIFIES PIPELINE PRESSURE

INDIA’S ABHAYRAB VACCINE INCIDENT EXPOSES A BIGGER RISK: PHARMACEUTICAL SUPPLY-CHAIN INTEGRITY IS BECOMING A PUBLIC-HEALTH PRIORITY

Next-Generation Vaccinology & In Silico mRNA Platforms: GSK Advances Dual-Antigen (HA + NA) mRNA Seasonal Influenza Candidate to Phase 3 Trials – Challenging Moderna Following Superior Immune Responses in Young and Older Adult Cohorts

Targeted Thoracic Oncology: AstraZeneca and Hutchmed Report Statistically Significant Progression-Free Survival Benefit in Phase 3 Trial Evaluating First-Line Tagrisso® (Osimertinib) Plus Orpathys® (Savolitinib) in EGFRm / MET+ Advanced NSCLC

Pediatric Nutrition Litigation & Product Liability Defense: U.S. Federal Bellwether Jury Delivers Complete Defense Verdict for Mead Johnson (Reckitt) Over Enfamil – Rejecting Causation Claims in Preterm Necrotizing Enterocolitis (NEC)

Hematologic Oncology & Next-Gen Multispecifics: Roche Inks Potential $1.53 Billion Global Licensing Agreement for Simcere Zaiming’s Preclinical Trispecific T-Cell Engager SIM0660 (CD79a × CD19 × CD3) Targeting Relapsed B-Cell Malignancies and Autoimmune Disorders

Agricultural Life Sciences & Global Agrifood Resilience: Bayer Launches First 2 of 10 Projected €500M+ Blockbusters – Advancing Plenexos® Insecticide and Preceon® Smart Corn System Alongside €400M in Operational Cost Savings

Facebook

Map

Online Members